Home
 /
Papers
 /
Biophysics
 /
Adaptor protein supersaturation drives innate immune signaling and cell fate
Preprint
Open access
V1
Top 1% · Validated by QED

Adaptor protein supersaturation drives innate immune signaling and cell fate

Alejandro Rodriguez Gama, Tayla Miller, Shriram Venkatesan +7 more
December 2025
 ·
bioRxiv
 ·
DOI 
10.1101/2023.03.20.533581
94
%
Reproducible
QED Impressions
This paper passed independent validation.
QED's automated review checked the evidence supporting each claim, the statistical methods, and whether the results are reproducible from the data provided.

It ranks in the top 1% of preprints assessed in Biophysics this quarter.
Run full QED analysis
Read paper
Save

Why this is interesting

By showing innate immune adaptors accumulate as supersaturated energy reservoirs—primed for explosive polymerization on demand—this work establishes a thermodynamic basis for inflammatory signal amplification and reveals an ancient immunity-longevity trade-off.

Author perspective

What is the most important insight, discovery, or finding from your paper that you would like other scientists to know?
“

This paper identified a 'phase change battery' mechanism to explain signal amplification by certain innate immune signaling proteins.

”
Randal Halfmann

QED claims analysis

Summary

Specific death fold domain (DFD) adaptors in inflammatory signalosomes function as biological phase change materials by maintaining constitutive supersaturation through sequence-encoded nucleation barriers, enabling them to store energy that powers on-demand signal amplification and cell fate decisions independently of cellular metabolism, while pathway-specific nucleating interactions prevent deleterious crosstalk and adaptor supersaturation levels inversely correlate with cell lifespan across human tissues.

See full analysis
Main Claim 1 –

Subset of DFDs encode nucleation barriers enabling supersaturation

Supporting evidence

  • Nucleation barriers are restricted to inflammatory signalosome adaptor DFDs
  • Adaptor DFD nucleation barriers are conserved across metazoans
Main Claim 2 –

DFD nucleation barriers amplify signaling and sensitize cells to death

Main Claim 3 –

Innate immune adaptor ASC is endogenously supersaturated in vivo

Supporting evidence

  • DFD nucleating interactions are pathway-specific with minimal crosstalk

Abstract

How minute pathogenic signals trigger decisive immune responses is a fundamental question in biology. Classical signaling often relies on ATP-driven enzymatic cascades, but innate immunity frequently employs death fold domain (DFD) self-assembly. The energetic basis of this assembly is unknown. Here, we show that specific DFDs function as energy reservoirs through metastable supersaturation. Characterizing all 109 human DFDs, we identified sequence-encoded nucleation barriers specifically in the central adaptors of inflammatory signalosomes, allowing them to accumulate far above their saturation concentration while remaining soluble and poised for activation. We demonstrate that the inflammasome adaptor ASC is constitutively supersaturated in vivo, retaining energy that powers on-demand cell death. Swapping a non-supersaturable DFD in the apoptosome with a supersaturable one sensitized cells to sublethal stimuli. Mapping all DFD nucleating interactions revealed that supersaturated adaptors are triggered to polymerize specifically by other DFDs in their respective pathways, limiting potentially deleterious crosstalk. Across human cell types, adaptor supersaturation strongly correlates with cell turnover, implicating this thermodynamic principle in the trade-off between immunity and longevity. Profiling homologues from fish and sponge, we find nucleation barriers to be conserved across metazoa. These findings reveal DFD adaptors as biological phase change materials in thermal batteries to power cellular life-or-death decisions on demand.

Related papers

How the QED Score works

QED Score is a validated AI-based quality metric that evaluates life science papers on two dimensions: originality and validity. Each manuscript is anonymized, broken down into its claims and supporting evidence, and examined by specialized AI agents for statistical rigor, consistency across figures, and fit with the existing literature. Scores are percentile ranks, so they're comparable across fields. In blinded tests, expert professors sided with QED Score over journal rank in 75% of decisive cases.
Read the methodology

Free access for academic researchers

Create your free QED account to validate your research, strengthen grant proposals, and uncover scientific insights.
We've sent you an access link.
Please check your inbox.

Didn't get your email? Check your spam folder or reach out to info@qedscience.com

Oops! Something went wrong while submitting the form.
Looking for QED for pharma, biotech or life science organizations?